GENOME ANNOUNCEMENT {#s0}
===================

*Salmonella* spp. are the leading cause of bacterial gastroenteritis in North America, with over 1.7 million cases per annum ([@B1]). Public health jurisdictions are replacing traditional serotyping with whole-genome sequencing (WGS) methodologies for quicker and more accurate outbreak detection and surveillance activities ([@B2]). To this end, we previously developed an *in silico* serotyping platform for *Salmonella* ([@B3], [@B4]).

Unfortunately, the large amount of raw data available in the SRA are primarily composed of Illumina short reads which cannot circularize the *Salmonella* genome as one contiguous nucleic acid molecule. As of November 2017, the number of fully closed genomes is 501 for *Salmonella enterica* and 4 for *Salmonella bongori*. Therefore, we sequenced 36 diverse serotypes of *Salmonella* using a combination of Illumina and PacBio technologies to produce high-quality genomes for public health and comparative genomics applications. This data set represents 25 novel serotypes with closed reference genomes.

Genomic DNA was isolated using the automated Qiagen EZ1 DNA tissue kit, using the manufacturer's protocol, except 180 μl of G2 buffer was used with 10 μl of proteinase K and 10 μl of lysozyme (10 mg/ml; Sigma-Aldrich, Gillingham, UK). PacBio sequencing was performed at the Génome Québec Innovation Centre (McGill University, Quebec, Canada) using single-molecule real-time (SMRT) cells in an RSII sequencer, which produced 100,000 to 150,000 reads per sample, with an average read length of 6,000 bp. The PacBio read sets were assembled into circular consensus sequences using the HGAP workflow 1.1.13. Illumina sequencing on MiSeq version 3 (600-cycle kit) using Nextera XT libraries was performed at the National Microbiology Laboratory at Winnipeg (Winnipeg, Manitoba, Canada) to a target of 60-fold coverage. The quality of the Illumina read sets was examined using FastQC (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>). Illumina read correction was performed using Lighter version 1.1.1 (<https://github.com/mourisl/Lighter>). Corrected Illumina reads were then mapped to the PacBio assembly using Bowtie2 version 2.1.0 (<http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>) using the very-sensitive-local option. The output was sorted and converted into a bam file using SAMtools version 1.3 (<http://samtools.sourceforge.net/>) and input to Pilon version 1.2.2 (<https://github.com/broadinstitute/pilon>). The process was performed iteratively on the corrected assemblies until no changes were made to the output. Final assemblies were examined using Gap5 software version 1.2.14 (<http://www.sanger.ac.uk/science/tools/gap5>). Completed assemblies were processed through the *Salmonella In Silico* Typing Resource (SISTR) ([@B3], [@B4]) to confirm that the *in silico* predictions matched the serotype previously performed by our OIE Reference Laboratory for Salmonellosis in Guelph, Ontario, Canada.

Closed reference genomes provide great value to an understanding of the biology of pathogens, and as such, it is important that genome repositories contain as many of them as possible. These would make important contributions as reference sequences for the WGS assembly of isolates of the same or highly similar serotypes, as well as provide more accurate genomes for comparative and epidemiological studies on outbreak detection and surveillance of *Salmonella*.

Accession number(s). {#s1}
--------------------

The genome sequences for these 36 *Salmonella* isolates have been deposited in DDBJ/ENA/NCBI under BioProject no. PRJNA294295. The GenBank accession numbers are listed in [Table 1](#tab1){ref-type="table"}. The raw sequence data are available in the Sequence Read Archive.

###### 

*Salmonella* strains sequenced in this study, by serotype

  Serotype                            Isolate no.   GenBank accession no.                                       Genome size (bp)
  ----------------------------------- ------------- ----------------------------------------------------------- ------------------
  Antsalova                           S01-0511      [CP019116](https://www.ncbi.nlm.nih.gov/nuccore/CP019116)   4,648,086
  Apapa                               SA20060561    [CP019403](https://www.ncbi.nlm.nih.gov/nuccore/CP019403)   4,801,658
  Bardo                               SA20113257    [CP019404](https://www.ncbi.nlm.nih.gov/nuccore/CP019404)   4,849,139
  Bergen                              ST350         [CP019405](https://www.ncbi.nlm.nih.gov/nuccore/CP019405)   4,801,835
  Blegdam                             S-1824        [CP019406](https://www.ncbi.nlm.nih.gov/nuccore/CP019406)   4,693,979
  Borreze                             SA20041063    [CP019407](https://www.ncbi.nlm.nih.gov/nuccore/CP019407)   4,777,558
  Braenderup                          SA20026289    [CP022490](https://www.ncbi.nlm.nih.gov/nuccore/CP022490)   4,734,880
  Crossness                           1422-74       [CP019408](https://www.ncbi.nlm.nih.gov/nuccore/CP019408)   4,847,468
  Derby                               SA20035215    [CP022494](https://www.ncbi.nlm.nih.gov/nuccore/CP022494)   4,850,334
  Djakarta                            S-1087        [CP019409](https://www.ncbi.nlm.nih.gov/nuccore/CP019409)   4,668,861
  Hillingdon                          N1529-D3      [CP019410](https://www.ncbi.nlm.nih.gov/nuccore/CP019410)   4,618,056
  Hvittingfoss                        SA20014981    [CP022503](https://www.ncbi.nlm.nih.gov/nuccore/CP022503)   4,940,239
  India                               SA20085604    [CP022015](https://www.ncbi.nlm.nih.gov/nuccore/CP022015)   5,395,280
  Johannesburg                        ST203         [CP019411](https://www.ncbi.nlm.nih.gov/nuccore/CP019411)   4,651,794
  Kentucky                            SA20030505    [CP022500](https://www.ncbi.nlm.nih.gov/nuccore/CP022500)   4,782,363
  Koessen                             S-1501        [CP019412](https://www.ncbi.nlm.nih.gov/nuccore/CP019412)   4,566,169
  Krefeld                             SA20030536    [CP019413](https://www.ncbi.nlm.nih.gov/nuccore/CP019413)   4,942,273
  Macclesfield                        S-1643        [CP022117](https://www.ncbi.nlm.nih.gov/nuccore/CP022117)   4,822,139
  Manchester                          ST278         [CP019414](https://www.ncbi.nlm.nih.gov/nuccore/CP019414)   4,532,753
  Manhattan                           SA20084699    [CP022497](https://www.ncbi.nlm.nih.gov/nuccore/CP022497)   4,732,484
  Mbandaka                            SA20026234    [CP022489](https://www.ncbi.nlm.nih.gov/nuccore/CP022489)   4,796,292
  Moscow                              S-1843        [CP019415](https://www.ncbi.nlm.nih.gov/nuccore/CP019415)   4,690,402
  Nitra                               S-1687        [CP019416](https://www.ncbi.nlm.nih.gov/nuccore/CP019416)   4,691,807
  Onderstepoort                       SA20060086    [CP022034](https://www.ncbi.nlm.nih.gov/nuccore/CP022034)   4,774,926
  Ouakam                              SA20034636    [CP022116](https://www.ncbi.nlm.nih.gov/nuccore/CP022116)   4,874,915
  Quebec                              S-1267        [CP022019](https://www.ncbi.nlm.nih.gov/nuccore/CP022019)   4,626,699
  Saintpaul                           SA20031783    [CP022491](https://www.ncbi.nlm.nih.gov/nuccore/CP022491)   4,775,303
  subsp. II 55:k:z~39~                1315K         [CP022139](https://www.ncbi.nlm.nih.gov/nuccore/CP022139)   4,859,044
  subsp. II 57:z~29~:z~42~            ST114         [CP022467](https://www.ncbi.nlm.nih.gov/nuccore/CP022467)   4,719,375
  subsp. IIIa 53:z~4~,z~23~,z~32~:-   SA20100345    [CP022504](https://www.ncbi.nlm.nih.gov/nuccore/CP022504)   4,586,333
  subsp. IIIb 50:k:z                  MZ0080        [CP022142](https://www.ncbi.nlm.nih.gov/nuccore/CP022142)   5,076,950
  subsp. IIIb 65:c:z                  SA20044251    [CP022135](https://www.ncbi.nlm.nih.gov/nuccore/CP022135)   4,913,978
  subsp. V 66:z~41~:-                 SA19983605    [CP022120](https://www.ncbi.nlm.nih.gov/nuccore/CP022120)   4,468,959
  Wandsworth                          SA20092095    [CP019417](https://www.ncbi.nlm.nih.gov/nuccore/CP019417)   4,916,040
  Waycross                            SA20041608    [CP022138](https://www.ncbi.nlm.nih.gov/nuccore/CP022138)   4,812,886
  Yovokome                            S-1850        [CP019418](https://www.ncbi.nlm.nih.gov/nuccore/CP019418)   4,640,929

\[This article was published on 18 January 2018 with a byline that lacked Marisa Rankin. The byline was updated in the current version, posted on 27 March 2018.\]

We thank Stephanie Brumwell, Madison McGrogan, and Travis Blimkie for technical support and Marisa Rankin for her help with proofreading the assemblies. We also thank the NCBI PGAP team for annotation services; McGill University, Genome Québec Innovation Centre, Montréal, Québec, for PacBio sequencing; and our colleagues Morag Graham and Matthew Walker at the PHAC National Microbiology Laboratory at Winnipeg, Manitoba, Canada, for the Illumina MiSeq sequencing. We sincerely thank the following for providing isolates: Roger Johnson, Gitanjali Arya, Linda Cole, Ketna Mistry, Ann Perets, and Betty Wilkie at OIE Reference Laboratory for Salmonellosis, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada; Danielle Daignault at the National Microbiology Laboratory, Public Health Agency of Canada, St. Hyacinthe, Quebec, Canada; Helen Tabor at the National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada; Muna Anjum, Sarah North, and Victoria Barrett at the Animal and Plant Health Agency, United Kingdom; Durda Slavic at the Animal Health Laboratory, University of Guelph, Guelph, Ontario, Canada; John Devenish at the Animal Health Microbiology Laboratory, Canadian Food Inspection Agency, Ottawa, Ontario, Canada; Danuta Kunikowska at the Department of Molecular Microbiology and Serology, Medical University of Gdańsk, National Salmonella Centre, Poland; Vanessa Allen, Anne Maki, and Analyn Peralta at the Enteric Section of the Public Health Ontario Laboratory, Toronto, Ontario, Canada; Francois-Xavier Weill at the Institut Pasteur, Paris, France; Gudrun Overesch at the Institute for Veterinary Bacteriology, University of Berne, Berne, Switzerland; Julie-Hélène Fairbrother and Olivia Labrecque at the Laboratoire d'Épidémiosurveillance Animale du Québec, Saint-Hyacinthe, Quebec, Canada; Martin Cormican and Niall Delappe at the National Salmonella, Shigella, and Listeria Reference Laboratory, Galway University Hospital, Galway, Ireland; and Steffen Porwollik at the Vaccine Research Institute of San Diego, San Diego, CA, USA.

Phenotypic serotyping of all *Salmonella* strains was performed by our colleagues at the OIE Reference Laboratory for Salmonellosis, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada.

This study was funded by the Public Health Agency of Canada.
